{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:57:25Z","timestamp":1780369045434,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-024-05178-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:55:34Z","timestamp":1734515734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Seven versus 14\u00a0days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-9763","authenticated-orcid":false,"given":"Beatriz","family":"Arns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-6294","authenticated-orcid":false,"given":"Andre C.","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-4853","authenticated-orcid":false,"given":"Guilherme G. L.","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-1247","authenticated-orcid":false,"given":"Ana Carolina Pe\u00e7anha","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-738X","authenticated-orcid":false,"given":"Juliana Pe\u00e7anha","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8070-6913","authenticated-orcid":false,"given":"Daniella Cunha","family":"Birriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-9629","authenticated-orcid":false,"given":"Daniel Haase","family":"Lanziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"da Cunha Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glecia Carla","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanildes","family":"de F\u00e1tima Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente C\u00e9s","family":"de Souza Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciele F\u00e1tima","family":"da Silva Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-6580","authenticated-orcid":false,"given":"Ver\u00f4nica","family":"de Fran\u00e7a Diniz Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francielle Constantino","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz Nunes","family":"Gobatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-0686","authenticated-orcid":false,"given":"Val\u00e9ria Paes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-9413","authenticated-orcid":false,"given":"F\u00e1bio Holanda","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Maria Dantas","family":"de Maio Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairo Daniel Nunes","family":"de Oliveira Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Menezes","family":"Irineu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-6590","authenticated-orcid":false,"given":"Jaqueline Driemeyer Correia","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-3467","authenticated-orcid":false,"given":"Guilhermo Prates","family":"Sesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-1351","authenticated-orcid":false,"given":"Crepin Aziz Jose Oluwafoumi","family":"Agani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-6092","authenticated-orcid":false,"given":"Tiago Marcon","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-5018","authenticated-orcid":false,"given":"Liliane Spencer Bittencourt","family":"Brochier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7547-1815","authenticated-orcid":false,"given":"Bruna Silveira","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-6132","authenticated-orcid":false,"given":"Bruno Martins","family":"Tomazini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-9696","authenticated-orcid":false,"given":"Bruno Adler Maccagnan Pinheiro","family":"Besen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-3800","authenticated-orcid":false,"given":"Adriano Jose","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-3601","authenticated-orcid":false,"given":"Viviane Cordeiro","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5071-3775","authenticated-orcid":false,"given":"Giovana Marssola","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5331-4837","authenticated-orcid":false,"given":"Alexandre P.","family":"Zavascki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"OPTIMISE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaysa","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4006-2099","authenticated-orcid":false,"given":"Thaissa","family":"Torrezini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-719X","authenticated-orcid":false,"given":"Euclimeire","family":"da Silva Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9605-3491","authenticated-orcid":false,"given":"Jamile Freire Barreto","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8592-7769","authenticated-orcid":false,"given":"Jaime Paula Pessoa Linhares","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"de Almeida e Pontes Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-3263","authenticated-orcid":false,"given":"Ren\u00e9 Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassia","family":"Righy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Turon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"5178_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"5178_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","volume":"49","author":"A Tabah","year":"2023","unstructured":"Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49:178\u201390.","journal-title":"Intensive Care Med"},{"key":"5178_CR3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/cid\/ciad100","volume":"76","author":"M Falcone","year":"2023","unstructured":"Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis. 2023;76:2059\u201369.","journal-title":"Clin Infect Dis"},{"key":"5178_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1473-3099(18)30792-8","volume":"19","author":"AJ Stewardson","year":"2019","unstructured":"Stewardson AJ, Marimuthu K, Sengupta S, Allignol A, El-Bouseary M, Carvalho MJ, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19:601\u201310.","journal-title":"Lancet Infect Dis"},{"key":"5178_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"J-L Vincent","year":"2020","unstructured":"Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323:1478\u201387.","journal-title":"JAMA"},{"key":"5178_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cmi.2022.08.024","volume":"29","author":"RA Lee","year":"2023","unstructured":"Lee RA, Stripling JT, Spellberg B, Centor RM. Short-course antibiotics for common infections: what do we know and where do we go from here? Clin Microbiol Infect. 2023;29:150\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"5178_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmi.2022.04.005","volume":"29","author":"B Spellberg","year":"2023","unstructured":"Spellberg B, Rice LB. The shorter is better movement: past, present, future. Clin Microbiol Infect. 2023;29:141\u20132.","journal-title":"Clin Microbiol Infect"},{"key":"5178_CR8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/cid\/ciy1134","volume":"69","author":"N Wald-Dickler","year":"2019","unstructured":"Wald-Dickler N, Spellberg B. Short-course antibiotic therapy-replacing constantine units with \u201cshorter is better.\u201d Clin Infect Dis. 2019;69:1476\u20139.","journal-title":"Clin Infect Dis"},{"key":"5178_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cmi.2023.05.022","volume":"29","author":"C Yek","year":"2023","unstructured":"Yek C, Lawandi A, Evans SR, Kadri SS. Which trial do we need? Optimal antibiotic duration for patients with sepsis. Clin Microbiol Infect. 2023;29:1232\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"5178_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/QCO.0000000000000861","volume":"35","author":"SF Haddad","year":"2022","unstructured":"Haddad SF, Allaw F, Kanj SS. Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens. Curr Opin Infect Dis. 2022;35:614\u201320.","journal-title":"Curr Opin Infect Dis"},{"key":"5178_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma T, Chihara S, Costin B, Treggiari MM, Bartz RR, Raghunathan K, et al. Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw Open. 2023;6: e2249353.","journal-title":"JAMA Netw Open"},{"key":"5178_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28:521\u201347.","journal-title":"Clin Microbiol Infect"},{"key":"5178_CR13","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Esbl K, Amp C, Enterobacterales C-R, Aeruginosa P, CRAB, et al. IDSA 2024 guidance on the treatment of antimicrobial resistant gram-negative infections. [cited 2024 Aug 1]. Available from: https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/","DOI":"10.1093\/cid\/ciae403"},{"key":"5178_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2213-2600(23)00418-6","volume":"12","author":"Y Mo","year":"2024","unstructured":"Mo Y, Booraphun S, Li AY, Domthong P, Kayastha G, Lau YH, et al. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial. Lancet Respir Med. 2024;12:399\u2013408.","journal-title":"Lancet Respir Med"},{"key":"5178_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40121-023-00897-9","volume":"13","author":"B Arns","year":"2024","unstructured":"Arns B, Horvath JDC, Rech GS, Sesin GP, Agani CAJO, da Rosa BS, et al. A randomized, open-label, non-inferiority clinical trial assessing 7 versus 14 days of antimicrobial therapy for severe multidrug-resistant gram-negative bacterial infections: the OPTIMISE trial protocol. Infect Dis Ther. 2024;13:237\u201350.","journal-title":"Infect Dis Ther"},{"key":"5178_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1745-6215-11-32","volume":"11","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32.","journal-title":"Trials"},{"key":"5178_CR17","unstructured":"Caderno 2 - Crit\u00e9rios Diagn\u00f3sticos de Infec\u00e7\u00e3o Relacionada \u00e0 Assist\u00eancia \u00e0 Sa\u00fade.pdf [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/www.gov.br\/anvisa"},{"key":"5178_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"5178_CR19","unstructured":"ESCMID-European Society of Clinical Microbiology, Diseases I. eucast: EUCAST [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/www.eucast.org\/"},{"key":"5178_CR20","unstructured":"Clsi. M100: Performance Standards for Antimicrobial Susceptability Testing. 2021."},{"key":"5178_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"5178_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"5178_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2215\/CJN.09530913","volume":"9","author":"T Fujii","year":"2014","unstructured":"Fujii T, Uchino S, Takinami M, Bellomo R. Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 2014;9:848\u201354.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5178_CR24","unstructured":"The R Project for Statistical Computing [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/www.r-project.org\/"},{"key":"5178_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00134-022-06690-5","volume":"48","author":"A Bougl\u00e9","year":"2022","unstructured":"Bougl\u00e9 A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, et al. Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. 2022;48:841\u20139.","journal-title":"Intensive Care Med"},{"key":"5178_CR26","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon J-Y, Chevret S, Thomas F, Wermert D, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588\u201398.","journal-title":"JAMA"},{"key":"5178_CR27","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2020.6348","volume":"323","author":"E von Dach","year":"2020","unstructured":"von Dach E, Albrich WC, Brunel A-S, Prendki V, Cuvelier C, Flury D, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323:2160\u20139.","journal-title":"JAMA"},{"key":"5178_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","volume":"69","author":"D Yahav","year":"2019","unstructured":"Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69:1091\u20138.","journal-title":"Clin Infect Dis"},{"key":"5178_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041290","volume":"7","author":"G Capellier","year":"2012","unstructured":"Capellier G, Mockly H, Charpentier C, Annane D, Blasco G, Desmettre T, et al. Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PLoS ONE. 2012;7: e41290.","journal-title":"PLoS ONE"},{"key":"5178_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2215","volume":"370","author":"Y Mo","year":"2020","unstructured":"Mo Y, Lim C, Watson JA, White NJ, Cooper BS. Non-adherence in non-inferiority trials: pitfalls and recommendations. BMJ. 2020;370: m2215.","journal-title":"BMJ"},{"key":"5178_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/cid\/ciac809","volume":"76","author":"ML Metersky","year":"2023","unstructured":"Metersky ML, Klompas M, Kalil AC. Less is more: a 7-day course of antibiotics is the evidence-based treatment for pseudomonas aeruginosa ventilator-associated pneumonia. Clin Infect Dis. 2023;76:750\u20132.","journal-title":"Clin Infect Dis"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05178-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:09:58Z","timestamp":1734516598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05178-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5178"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05178-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and amendments were approved by the research ethics committee (institutional review board, IRB) of the coordinating centre (Hospital Moinhos de Vento), as well as IRBs from all other participant sites. Written informed consent was obtained from the patients (or from a legal representative, if the patient was not capable of providing it at that moment).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BA received support for attending meetings and\/or travel by MSD. G.M.N received payment for lectures for Pfizer and MSD and received support for attending meetings and\/or travel by Pfizer. A.P.Z. is a research fellow of the National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Brazil. All other authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}